Syndax Pharmaceuticals Inc.
SNDX | NASDAQ
$18.07
+$0.45 (+2.55%)
At close: Sep 21, 2026, 4:00 PM ET
$18.11
+$0.04 (+0.22%)
Pre-market:
Sep 22, 2026, 5:33 AM ET
Market Data
Market Cap $1.56B
Enterprise Value $1.64B
Beta 0.37
Average Volume 1.75M
Shares Outstanding (Diluted) 88.99M
Shares Change YoY 3.07%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US87164F1057
Price Performance
Price Change 1M -8.1%
Price Change 3M -7.8%
Price Change 6M -25.3%
Price Change YTD -15.2%
Price Change 1Y 21.4%
Price Change 3Y 13.2%
Price Change 5Y -3.9%
1M CAGR (ann.) -10.8%
1Y CAGR (ann.) 19.5%
5Y CAGR (ann.) -0.8%
All-Time CAGR 3.7%
Valuation
PE Ratio -7.17
Forward PE 269.11
PEG Ratio -0.15
Forward PEG 0.12
PS Ratio 6.35
Forward PS 3.50
PB Ratio 106.05
P/FCF Ratio -5.90
P/Adj. FCF Ratio -4.81
P/OCF Ratio -7.29
EV/Sales 6.52
EV/EBIT -12.14
EV/EBITDA -12.15
EV/FCF -6.06
Earnings Yield -13.9%
FCF Yield -16.9%
Adj. FCF Yield -20.8%
Financial Health
Net Debt $40.26M
Total Debt $589.38M
Cash & Short-Term Investments $547.86M
Total Assets $703.65M
Current Ratio 6.77
Quick Ratio 6.44
Debt / Equity Ratio 39.03
Debt / EBITDA -4.36
Debt / FCF -2.17
OCF / Debt -0.46
Interest Coverage -2.27
Altman Z-Score -1.12
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 97.5%
Operating Profit Margin -77.0%
EBITDA Margin -53.7%
Net Profit Margin -87.6%
FCF Margin -107.6%
Adj. FCF Margin -132.0%
SBC / Revenue 19.6%
SBC Impact (per share) -22.7%
Returns
Return on Assets -31.4%
Return on Equity -372.9%
Return on Invested Capital -32.1%
Return on Capital Employed -32.1%
Return on Tangible Assets -31.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 111.7%
Revenue CAGR 5Y 178.0%
Revenue CAGR 10Y 70.4%
EPS CAGR 3Y 13.2%
EPS CAGR 5Y -28.3%
EPS CAGR 10Y -2.1%
FCF CAGR 3Y -5.5%
FCF CAGR 5Y -37.2%
FCF CAGR 10Y -23.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y 60.3%
Revenue Growth Next 3Y 52.2%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $37
Price Target Upside 104.8%
Cash Flow
Operating Cash Flow $-270.99M
Free Cash Flow $-271.21M
Adj. Free Cash Flow $-332.67M
FCF Per Share -$2.48
OCF Per Share -$2.48
OCF/S Ratio -87.6%
Income Statement
Revenue $252M
Gross Profit $245.64M
Operating Income $-194.17M
EBITDA $-135.25M
Net Income $-220.77M
EPS (Diluted) -$2.52
Revenue / Employee $845.65K
Profit / Employee $-740.82K
Employees 298
Add to Watchlist
Select watchlists to add or remove SNDX